Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 29493370 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematological diseases | NA | NA | NA | unclassified | |
| haploidentical stem cell transplantation (haplo-sct) is currently a suitable alternative worldwide for patients with hematological diseases, who lack human leukocyte antigen (hla)-matched siblings or unrelated donors. | |||||||
| 29493370 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| haploidentical stem cell transplantation (haplo-sct) is currently a suitable alternative worldwide for patients with hematological diseases, who lack human leukocyte antigen (hla)-matched siblings or unrelated donors. | |||||||
| 30998182 | HLA (HLA) | hematological diseases | NA | NA | NA | unclassified | |
| allogeneic hematopoietic stem cell transplantation (allo-hsct) is widely used in the treatment of hematological diseases, hla incompatibility is displayed in most cases. | |||||||
| 30998182 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| allogeneic hematopoietic stem cell transplantation (allo-hsct) is widely used in the treatment of hematological diseases, hla incompatibility is displayed in most cases. | |||||||
| 31483332 | HLA MATCHED (HLA-MATCHED) | hematological diseases | NA | cyclophosphamide | NA | unclassified | |
| purpose of reviewthis article is intended to review recent trends and improvements in haploidentical transplantation to understand its current status and future direction.recent findingsthe noninferiority of haploidentical donors compared with other donor sources, including hla-matched related or unrelated donors, has been demonstrated in patients with various hematological diseases. | |||||||
| 31483332 | HLA MATCHED (HLA-MATCHED) | haploidentical transplantation | NA | cyclophosphamide | NA | unclassified | |
| purpose of reviewthis article is intended to review recent trends and improvements in haploidentical transplantation to understand its current status and future direction.recent findingsthe noninferiority of haploidentical donors compared with other donor sources, including hla-matched related or unrelated donors, has been demonstrated in patients with various hematological diseases. | |||||||
| 32539316 | HLA MATCHED (HLA-MATCHED) | hematological diseases | NA | NA | NA | unclassified | |
| comparison of risk scoring systems in hla-matched related allogeneic hematopoietic stem cell transplantation: a retrospective cohort study objectiveallogeneic hematopoietic stem cell transplantation (ahsct) is a potentially curative treatment of choice for many hematological diseases. | |||||||
| 32539316 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| comparison of risk scoring systems in hla-matched related allogeneic hematopoietic stem cell transplantation: a retrospective cohort study objectiveallogeneic hematopoietic stem cell transplantation (ahsct) is a potentially curative treatment of choice for many hematological diseases. | |||||||
| 32539316 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| comparison of risk scoring systems in hla-matched related allogeneic hematopoietic stem cell transplantation: a retrospective cohort study. | |||||||
| 33772729 | HLA MISMATCHED (HLA-MISMATCHED) | hematological diseases | NA | NA | NA | unclassified | |
| selective t-cell depletion targeting cd45ra as a novel approach for hla-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases. | |||||||
Copyright 2024